Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Cell line
|
Drug
|
Regulatory
|
Confidence score(level)
|
Ref.
|
acc2451 |
JNK2 |
phosphorylation |
Tyr185 |
human |
Colorectal Cancer |
HT29 |
TRAIL + Cisplatin |
Enhancing |
5.0 (High)
|
15837763
|
acc2452 |
JNK2 |
phosphorylation |
Tyr185 |
human |
Hepatocellular Carcinoma |
HepG2 |
TRAIL + Cisplatin |
Enhancing |
5.0 (High)
|
15837763
|
acc2453 |
TRIP13 |
phosphorylation |
Tyr56 |
human |
Head and Neck Cancer |
UM-SCC-1 |
Cetuximab |
Enhancing |
5.0 (High)
|
34111559
|
acc2454 |
TRIP13 |
phosphorylation |
Tyr56 |
human |
Head and Neck Cancer |
UM-SCC-1 |
Radiotherapy |
Impairing |
5.0 (High)
|
34111559
|
acc2455 |
TRIP13 |
phosphorylation |
Tyr56 |
human |
Head and Neck Cancer |
UM-SCC-11A |
Cetuximab |
Enhancing |
5.0 (High)
|
34111559
|
acc2456 |
TRIP13 |
phosphorylation |
Tyr56 |
human |
Head and Neck Cancer |
UM-SCC-11A |
Radiotherapy |
Impairing |
5.0 (High)
|
34111559
|
acc2457 |
TrkB |
phosphorylation |
Tyr |
human |
Neuroblastoma |
SH-SY5Y |
Retinoic acid |
Associated |
4.0 (Moderate) |
8394722
|
acc2458 |
TrkB |
phosphorylation |
Tyr |
human |
Neuroblastoma |
SMS-KCNR |
Retinoic acid |
Associated |
4.0 (Moderate) |
8394722
|
acc2459 |
TrkB |
phosphorylation |
Tyr |
human |
Neuroblastoma |
NGP-2 |
Retinoic acid |
Associated |
4.0 (Moderate) |
8394722
|
acc2460 |
TrkB |
phosphorylation |
Tyr |
human |
Neuroblastoma |
LAN-I-15N |
Retinoic acid |
Associated |
4.0 (Moderate) |
8394722
|
acc2461 |
MERTK |
phosphorylation |
Tyr749 |
human |
Leukemia |
K562 |
Metformin |
Associated |
4.0 (Moderate) |
32460059
|
acc2462 |
TYRO3 |
phosphorylation |
Tyr681 |
human |
Leukemia |
K562 |
Metformin |
Associated |
4.0 (Moderate) |
32460059
|
acc2463 |
AXL |
phosphorylation |
Tyr779 |
human |
Leukemia |
K562 |
DXR |
Impairing |
5.0 (High)
|
32460059
|
acc2464 |
AXL |
phosphorylation |
Tyr779 |
human |
Leukemia |
K562 |
DXR |
Impairing |
5.0 (High)
|
32460059
|
acc2465 |
TYRO3 |
phosphorylation |
Tyr681 |
human |
Leukemia |
OCI/AML3 |
Metformin |
Associated |
4.0 (Moderate) |
32460059
|
acc2466 |
TYRO3 |
phosphorylation |
Tyr681 |
human |
Leukemia |
THP-1 |
Metformin |
Associated |
4.0 (Moderate) |
32460059
|
acc2467 |
AXL |
phosphorylation |
Tyr779 |
human |
Leukemia |
OCI/AML3 |
TP-0903 |
Impairing |
5.0 (High)
|
32460059
|
acc2468 |
AXL |
phosphorylation |
Tyr779 |
human |
Leukemia |
OCI/AML3 |
TP-0903 |
Impairing |
5.0 (High)
|
32460059
|
acc2469 |
AXL |
phosphorylation |
Tyr779 |
human |
Leukemia |
K562 |
TP-0903 |
Impairing |
5.0 (High)
|
32460059
|
acc2470 |
AXL |
phosphorylation |
Tyr779 |
human |
Leukemia |
K562 |
TP-0903 |
Impairing |
5.0 (High)
|
32460059
|
acc2471 |
AXL |
phosphorylation |
Tyr779 |
human |
Leukemia |
OCI/AML3 |
DXR |
Impairing |
5.0 (High)
|
32460059
|
acc2472 |
AXL |
phosphorylation |
Tyr779 |
human |
Leukemia |
OCI/AML3 |
DXR |
Impairing |
5.0 (High)
|
32460059
|
acc2473 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Leukemia |
OCI/AML2 |
Metformin |
Associated |
4.0 (Moderate) |
32460059
|
acc2474 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Leukemia |
OCI/AML3 |
Metformin |
Associated |
4.0 (Moderate) |
32460059
|
acc2475 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Leukemia |
THP-1 |
Metformin |
Associated |
4.0 (Moderate) |
32460059
|
acc2476 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Leukemia |
K562 |
Metformin |
Associated |
4.0 (Moderate) |
32460059
|
acc2477 |
p53 |
phosphorylation |
Ser15 |
human |
Melanoma |
DB-1 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2478 |
p53 |
phosphorylation |
Ser20 |
human |
Melanoma |
DB-1 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2479 |
p53 |
phosphorylation |
Ser37 |
human |
Melanoma |
SK-Mel-28 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2480 |
p53 |
phosphorylation |
Ser392 |
human |
Melanoma |
SK-Mel-28 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2481 |
p53 |
phosphorylation |
Ser37 |
human |
Melanoma |
DB-1 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2482 |
p53 |
phosphorylation |
Ser392 |
human |
Melanoma |
DB-1 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2483 |
p53 |
phosphorylation |
Ser15 |
human |
Melanoma |
SK-MEL-5 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2484 |
p53 |
phosphorylation |
Ser20 |
human |
Melanoma |
SK-MEL-5 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2485 |
p53 |
phosphorylation |
Ser37 |
human |
Melanoma |
SK-MEL-5 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2486 |
p53 |
phosphorylation |
Ser392 |
human |
Melanoma |
SK-MEL-5 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2487 |
p53 |
phosphorylation |
Ser15 |
human |
Melanoma |
SK-Mel-28 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2488 |
p53 |
phosphorylation |
Ser20 |
human |
Melanoma |
SK-Mel-28 |
Dacarbazine |
Enhancing |
5.0 (High)
|
18791269
|
acc2489 |
Chk1 |
phosphorylation |
Ser317 |
human |
Lung Cancer |
A549 |
Cisplatin |
Impairing |
5.0 (High)
|
35856403
|
acc2490 |
VEGFR2 |
phosphorylation |
Tyr1059 |
human |
Hepatocellular Carcinoma |
SMMC-7721 |
I131-metuximab |
Associated |
4.0 (Moderate) |
29210217
|
acc2491 |
VEGFR2 |
phosphorylation |
Tyr996 |
human |
Leukemia |
HL-60 |
SU4312 |
Associated |
4.0 (Moderate) |
34872003
|
acc2492 |
VEGFR2 |
phosphorylation |
Tyr996 |
human |
Leukemia |
K562 |
SU4312 |
Associated |
4.0 (Moderate) |
34872003
|
acc2493 |
VEGFR2 |
phosphorylation |
Tyr996 |
human |
Leukemia |
KG-1 |
SU4312 |
Associated |
4.0 (Moderate) |
34872003
|
acc2494 |
VEGFR2 |
phosphorylation |
Tyr996 |
human |
Leukemia |
HL-60 |
Cytarabine |
Associated |
4.0 (Moderate) |
34872003
|
acc2495 |
VEGFR2 |
phosphorylation |
Tyr996 |
human |
Leukemia |
K562 |
Cytarabine |
Associated |
4.0 (Moderate) |
34872003
|
acc2496 |
VEGFR2 |
phosphorylation |
Tyr996 |
human |
Leukemia |
KG-1 |
Cytarabine |
Associated |
4.0 (Moderate) |
34872003
|
acc2497 |
KLF4 |
phosphorylation |
Tyr20 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Enhancing |
5.0 (High)
|
32084531
|
acc2498 |
KLF4 |
phosphorylation |
Tyr20 |
human |
Breast Cancer |
HTR |
Tamoxifen |
Enhancing |
5.0 (High)
|
32084531
|
acc2499 |
Cdc2 |
phosphorylation |
Tyr15 |
human |
Ovarian Cancer |
HT29 |
PD0166285 |
Associated |
4.0 (Moderate) |
11719452
|
acc2500 |
Cdc2 |
phosphorylation |
Thr14 |
human |
Colorectal Cancer |
HT29 |
PD0166285 |
Associated |
4.0 (Moderate) |
11719452
|